Nippon Rika CO., Ltd.

Form 483 issued July 4, 2025 · ASHIKAGA, Japan

Inspection
Jun 30 – Jul 4, 2025
Investigator
Crystal Monroy
Observations
7
Pages
3
FEI number
3002807731

In short: On July 4, 2025, FDA issued a Form 483 with 7 observations to Nippon Rika CO., Ltd. in ASHIKAGA, TOCHIGI (FEI 3002807731) after an inspection that ran Jun 30 – Jul 4, 2025. The investigator was Crystal Monroy. Most observations concern laboratory controls and production.

At a glance

Laboratory controls and production account for 5 of 7 observations.

Laboratory controls3
Production2
Facilities & equipment1
Quality system1

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    The test procedures used in stability testing are not verified…

  2. 02

    Control of quality control samples of raw materials, intermediates, and APIs are inadequate. Specially, (A) Your…

  3. 03

    Laboratory control records are…

  4. 04

    Appropriate controls are not exercised over…

3 more observations

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Nippon Rika CO., Ltd.?

FDA listed 7 observations on this Form 483, mostly about laboratory controls, production and facilities & equipment. The opening words of each observation are shown on this page.

Who inspected Nippon Rika CO., Ltd.?

Crystal Monroy is named on this Form 483, for the inspection of Jun 30 – Jul 4, 2025. Each investigator has a profile showing what they cite most.

When was Nippon Rika CO., Ltd. inspected by FDA?

The inspection ran Jun 30 – Jul 4, 2025, and the Form 483 is dated July 4, 2025.

How do I get the full Form 483 for Nippon Rika CO., Ltd.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free